Skip to content

Innoviva, Inc. INVA Financing Cash Flow

Financing Cash Flow at other companies

Pfizer logo
PfizerPFE
-$2.86B+45.4%
Merck & Co. logo
Merck & Co.MRK
-$2.98B+48.2%
AbbVie logo
AbbVieABBV
$919M+173%
Insmed logo
InsmedINSM
$29.51M+1.8%
Savara logo
SavaraSVRA
-$195K-108%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$54.87M+712%

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.41B+9.7%
P/E3.5×
P/S4.2×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s financing cash flow?
Innoviva, Inc. (INVA) reported financing cash flow of -$20.15M in Q1 2026.
How has Innoviva, Inc.'s financing cash flow changed year-over-year?
Innoviva, Inc.'s financing cash flow decreased by 11108.7% year-over-year, from $183K to -$20.15M.
What is the long-term trend for Innoviva, Inc.'s financing cash flow?
Over 2 years (2021 to 2023), Innoviva, Inc.'s financing cash flow has grown at a -38.4% compound annual growth rate (CAGR), from -$452.5M to -$171.84M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.